Charoen Mankongpaisarnrung is a Gastroenterology physician. OpenAlex indexes 49 publications with 251 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
435 Phalen Blvd
Saint Paul, MN 551305302
Telephone
651-254-8680Provider last certified this registry record 28 Jun 2022.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20223 payments
- Janssen Biotech, Inc.Program year20221 payment
- AbbVie Inc.Program year20213 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
83.2%Osmotic Laxative30.8%Gavilyte-G69%Gavilyte-C17%Peg-3350 And Electrolytes13%Part D≥256 patientsProton pump inhibitor27.6%Omeprazole85%Pantoprazole Sodium15%Part D≥122 patients+ 3 more classes in this area
Nervous system
9%Benzodiazepine6.6%Midazolam hydrochloride100%Part B, office-administered≥19 patientsOpioid Agonist1.2%Fentanyl citrate100%Part B, office-administered≥15 patients+ 1 more class in this area
Cardiovascular
2.9%Calcium channel blocker2%Diltiazem 24hr Er (Cd)100%Part D<11 patientsBile Acid Sequestrant0.9%Cholestyramine100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Review of Medical Management of Primary Biliary Cholangitis.
PubMed
2021 - Modes of death and clinical outcomes in adult patients with hypertrophic cardiomyopathy in Thailand
BMC Cardiovascular Disorders
2019 - Emerging Role of Vedolizumab in Managing Refractory Immune Checkpoint Inhibitor-Induced Enteritis
ACG Case Reports Journal
2018 - Cholecystokinin Receptor-Targeted Polyplex Nanoparticle Inhibits Growth and Metastasis of Pancreatic Cancer
Cellular and Molecular Gastroenterology and Hepatology
2018 - Therapeutic Effect of Vancomycin in UC Patients Associated With PSC: Case Series
The American Journal of Gastroenterology
2017
Similar KOLs
Other experts from the same institution or the same specialty.
Josep M. Llovet
Institució Catalana de Recerca i Estudis Avançats
Joseph J.�Y. Sung
Nanyang Technological University
Neeraj Bhala
The Royal Melbourne Hospital
Jordi Bruix
Hospital Clínic de Barcelona
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”